{"disease":{"id":"multiple-myeloma-in-combination-with-lenalidomide-and-dexamethasone-in-newly-diagnosed-patients-who-are-ineligible-for-autologous-stem-cell-transplant-and-in-patients-with-relapsed-or-refractory-multiple-myeloma-who-have-received-at-least-one-prior-therapy.md","name":"multiple myeloma in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with relapsed or refractory multiple myeloma who have received at least one prior therapy.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}